Drug Safety

, Volume 11, Issue 5, pp 310–317

Drug-Induced Dementia

Incidence, Management and Prevention
  • John M. Starr
  • Lawrence J. Whalley
Review Article Pharmacoepidemiology

DOI: 10.2165/00002018-199411050-00003

Cite this article as:
Starr, J.M. & Whalley, L.J. Drug-Safety (1994) 11: 310. doi:10.2165/00002018-199411050-00003

Summary

Drugs are a frequently cited cause of dementia. There is a paucity of data regarding the incidence of drug-induced dementia, but it has been estimated that over 10% of patients attending memory clinics have iatrogenic disease. Drugs may impair cognition indirectly via metabolic effects, such as hypoglycaemia, by alterations of immunological factors within the CNS, and by actions that interfere with synaptic transmission. Classes of drugs most frequently responsible are the benzodiazepines, antihypertensives and drugs with anticholinergic properties. Each of these classes is likely to produce a different pattern of neuro-psychological deficits. Prevention of drug-induced dementia will be aided by: (i) minimising the number of drugs prescribed; (ii) using shorter-acting preparations; (iii) avoiding agents that cross the blood-brain barrier where possible; (iv) evaluating renal and hepatic function regularly; and (v) briefly assessing cognitive function before treatment.

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • John M. Starr
    • 1
  • Lawrence J. Whalley
    • 2
  1. 1.Division of Geriatric MedicineHammersmith HospitalLondonEngland
  2. 2.Department of Mental HealthUniversity Medical BuildingsForesterhill, AberdeenScotland